Faculty – 2019 Drug Pricing and Reimbursement Stakeholder Summit


John Alter
VP, Patient and Health Impact Lead, Hospital Business Unit, PFIZER

view speaker profile

John Alter is currently Vice President, Global Health & Value lead and member of the leadership team of the Global Established Pharma Business Unit at Pfizer.  Health & Value functions include Pricing, Market Access, HEOR and Real World Data.

John joined Pfizer in 1998 and has held positions of increasing responsibilities in several functions/divisions including Corporate Finance, Global Manufacturing and Pharmaceutical Commercial Operations in North America, Latin America, Europe, Africa, Middle East and Asia Pacific.

John earned his undergraduate degree from Villanova University and his MBA from George Mason University and served as a U.S. Naval officer for six years before joining industry.  He is married with three children.


Jeff Krol
Executive Director, Managed Markets and Project Management, AVANIR PHARMACEUTICALS


Stuart Levine, M.D., MHA
Chief Medical and Innovation Officer, AGILON HEALTH

view speaker profile

Dr. Stuart Levine is currently the Chief Medical and Innovation Officer for Agilon Health, a physician group and IPA platform providing integrated and coordinated care in multiple geographies powered by advanced technology supported by Clayton, Dubilier and Rice. Dr Levine is also the CEO and President of Medical Innovations Inc., a health consulting firm for which he is the founder. Dr. Levine is the Chief Physician Advisor to Google Health Research. He is an operating advisor to some of the largest and most successful private equity firms in health care including Clayton, Dubilier and Rice.

Prior to leading his consulting firm, Dr. Levine served as the Chief Innovation and Clinical Care Officer at Blue Shield at California where he was responsible for the ACO initiative state-wide, clinical optimization across all partner provider groups/ systems and business lines, strategic planning, medical management infrastructure development and government programs and clinical innovations for the enterprise. He had previously served as the Vice President of Quality, and Vendor Management of External Clinical Programs at Blue Shield of California in San Francisco. There, he was responsible for developing and executing the quality programs which focused on improved health care processes and delivery.

Prior to rejoining Blue Shield, Dr. Levine served as the Executive Vice President and Executive Medical Director for Clinical Integration and Transformation Officer at Heritage Medical Systems where he was responsible for clinical optimization and innovation across the enterprise. In addition, Dr. Levine was responsible for putting together the joint venture between Trinity Health and Heritage Provider Group to form one of the largest integrated delivery system in the United States. Prior to this role at Heritage, he served as the Executive Vice President and Executive Medical Director of Arizona Priority Plus where he oversaw the clinical and administrative services including quality of care, outcomes and clinical services for Heritage Medical Services outside of California.

Prior to working at Arizona Priority Plus, Dr. Stuart Levine was the Executive Vice President and Chief Innovation Officer of Accretive Health and was the leader of the company’s enhancement of physician engagement strategies, clinical quality capability, and future market development of Accretive Health’s Quality and Total Cost of Care and Population Health program.

Dr. Levine was the Corporate Medical Director and Regional Medical Director of HealthCare Partners Medical Group of California where he was responsible for the company’s clinical-focused initiatives for 6 years, prior to and through the transition to DaVita, including company-wide clinical optimization and innovation, mergers and acquisitions as well as corporate and regional operations.

Prior to joining HealthCare Partners Medical Group, Dr. Levine was the Medical Director for SCAN Health Plan for 10 years. Here he was responsible for all clinical operations for the HMO as well as all clinical operations for network management, provider services and contracting. He also oversaw the CME program and participated in all other aspects of HMO operations where clinical participation was essential.

Dr. Levine initially started out his physician leadership career as the CEO of PsychCare Alliance and Topaz Health, where grew this to become the largest behavioral health medical group in the United States doing full risk and collaborative behavioral health care.

Dr. Levine is an Assistant Professor of Internal Medicine and Psychiatry at the University of California, Los Angeles David Geffen School of Medicine since 1992 as well as resident expert on Population Health. Dr Levine was also recently appointed Assistant Clinical Professor of Internal Medicine at Stanford University School of Medicine and has been active in their teaching programs around population health and future of medicine since 2014. He has published three dozen articles, book chapters and other abstracts in a variety of referred journals in addition to multiple national presentations and other works. This has included a wide array of subjects including population health, palliative care, the future of medicine, risk stratification and collaborative care in behavioral health as a principal investigator of IMPACT depression care.

Prior to his career in medicine, he has served as an administrator at the University of California, San Francisco Medical Center and the University of Chicago Medical Center.

Dr. Levine completed his Psychiatry Residency at UCLA NPI and internship in Medicine and Pediatrics at LAC-USC and is board certified in psychiatry. He later taught and ran the consultation liaison psychiatry service at USC-LAC and the HIV services for LA County -USC Hospital.

Dr. Levine graduated from the University of Illinois College Of Medicine at Chicago as a James Scholar. He also holds a Master’s degree in Healthcare Administration from George Washington University in Washington, D.C. Dr. Levine is also a graduate of fellowships at University of California, San Francisco/ CHCF in health care leadership and health care policy as well as a fellowship at Stanford University in Biodesign and Medical innovation. He currently serves on a number of boards for health care companies including as the President of the Board of California Health Care Foundation Leadership Alumni program and the Partners of Care Foundation.


Kendra Martello
Senior Director, Public Policy, MALLINCKRODT PHARMACEUTICALS

view speaker profile

Kendra is an experienced attorney, advocate, and government affairs professional skilled in strategic counseling, advocacy, legal and policy analysis, and government and regulatory affairs at top-tier multi-national law firms and industry-leading trade associations.

She is a successful advocate with experience in Congressional and state testimony and in engaging elected and appointed officials and professional staff in federal and state legislative bodies and executive agencies. She has presented at a multitude of conferences and events, regularly prepares briefings and materials for C-level executives, has worked extensively with third-party stakeholders, and has served regularly as a media spokesperson.

In her current role, she is responsible for state and federal policy on behalf of Mallinckrodt Pharmaceuticals, a multibillion-dollar specialty pharmaceutical company focused on the mission of Managing Complexity. Improving Lives. Mallinckrodt provides medicines to address unmet patient needs, particularly in the autoimmune and rare disease area, with a rich 150-year history in developing and marketing products to improve patient’s lives.

Kendra received her JD from American University’s Washington College of Law and her BA in Political Science from the University of Maryland. She also serves as the Chair of the Commission for Women in Alexandria, Virginia, which advises the Mayor and City Council on issues of importance to women and girls in the City.


Mallory O’Connor
Director, Healthcare Policy and Federal Programs, BIOTECHNOLOGY INNOVATION ORGANIZATION- BIO


Boxiong Tang
Senior Director, BEIGENE


Keren Tenenbaum
Assistant General Counsel, PFIZER

view speaker profile

Keren Tenenbaum is an Assistant General Counsel at Pfizer’s Legal Division. Prior to joining Pfizer, Ms. Tenenbaum was an associate at DLA Piper’s litigation department in New York.


Debbie Walters
Vice President and Assistant General Counsel, PFIZER